Oxford Sciences Innovation returned to reinvest in the smart echocardiogram technology spinout, helping increase its overall funding to nearly $60m.
Ultromics, a UK-based cardiovascular imaging technology provider spun out of University of Oxford, secured $33m yesterday in a series B round featuring the university’s venture capital partner, Oxford Sciences Innovation (OSI).
The round was led by Blue Venture Fund, a vehicle backed by 35 Blue Cross and Blue Shield Association health insurers, and also featured internet and technology group Alphabet’s GV unit as well as Optum Ventures, the corporate venturing arm of health services provider Optum.
Founded in 2017, Ultromics has developed two systems – EchoGo Core and EchoGo Pro – in partnership with the UK’s National Health Service that are designed to quickly and accurately check echocardiograms to assess heart condition.
By uploading echocardiograms to the cloud and analysing them using artificial intelligence, the technology can support rapid and accurate assessments in the diagnoses of heart conditions like coronary artery disease and amyloidosis.
OSI had…
Fernando Moncada Rivera
Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
